GSK
GSK
79 New Oxford Street
London, United Kingdom, WC1A 1DG
Tel: +44 (0)20 8047 5502
www.gsk.com
[email protected]
Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://innovativemedicine.jnj.com/emea/
Sanofi Oncology
At Sanofi Oncology, we are committed to transforming cancer care by developing innovative, first-in-class and best-in-class solutions focused on rare and difficult-to-treat blood cancers and solid tumors.
Cancer is complex, and we remain focused on advancing oncology innovation through an unwavering long-term determination to help extend lives, ease the burden and help restore hope to those impacted by cancer.
#weneversettle
Sanofi
46-48 Av. de la Grande Armée,
75017 Paris
France
https://www.sanofi.com/en
Pfizer Oncology
At Pfizer Oncology, we are at the forefront of a new era in cancer care. Our industry-leading portfolio and extensive pipeline includes game-changing mechanisms of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), small molecules, bispecifics and other immunotherapies. We are focused on delivering transformative therapies in some of the world’s most common cancers, including breast cancer, genitourinary cancer and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological and thoracic cancers, which includes lung cancer. Driven by science, we are committed to accelerating breakthroughs to extend and improve patients’ lives.
Pfizer Oncology
66 Hudson Blvd. E, New York, NY 10001
Tel: +1-212-733-3026
www.pfizer.com
Adaptive Biotechnologies
clonoSEQ® is a next-generation sequencing (NGS) test that enables precise and sensitive measurement of minimal residual disease (MRD) in blood cancers, such as leukemia and lymphoma. This test provides clinicians with valuable insights into disease monitoring, relapse detection, and treatment response. Now available in Europe, clonoSEQ empowers healthcare providers with advanced tools for better patient outcomes in the fight against hematologic malignancies.
Menarini Stemline
Menarini Stemline
Stemline Therapeutics GmbH
Grafenaustrasse 3, CH-6300 Zug – Switzerland
Linkedin https://www.linkedin.com/company/menarinistemline
Twitter: https://twitter.com/Stemline
www.menarinistemline.com
[email protected]
Oncopeptides
Gilead | Kite
Creating the Future of Oncology to Help Bring More Life to People With Cancer
About Kite
Kite, a Gilead Company, is a global biopharmaceutical company based in Santa Monica, California, focused on achieving cures with cell therapy. As the global cell therapy leader, Kite has treated more patients with CAR T-cell therapy than any other company. Kite has the largest in-house cell therapy manufacturing network in the world, spanning process development, vector manufacturing, clinical trial supply and commercial product manufacturing.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19 and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. Gilead acquired Kite in 2017.
AbbVie
Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics.
Amgen
One Amgen Center Drive, Thousand Oaks, CA, 91320-1799
Tel: +1 805-447-1000
www.amgen.com (can refer to “contact us” on this website for different email contacts)
Regeneron
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly translate science into medicine has led to numerous FDA-approved treatments and candidates in development. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, and through research initiatives such as the Regeneron Genetics Center. Visit www.Regeneron.com to learn more.
Roche
Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice.
Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.
